TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.
Dr. Kevin Kalinsky discusses the role of targeted therapy and clinical decision-making in managing estrogen-driven, ...
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
The article provides strategies for each zodiac sign to combat negative thoughts. From engaging in physical activities and ...
Immunotherapy advances in triple-negative breast cancer drive personalized treatments with immune checkpoint inhibitors, aiding subtype identification and new combination therapy developments.
As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...
The term colorectal cancer combines colon and rectal cancer, two parts of the intestine. The first part of the large ...
Timely receipt of guideline-concordant care can improve survival and may help mitigate racial and ethnic disparities in survival among patients with inflammatory breast cancer, researchers wrote.
Evercore ISI initiated coverage of Summit Therapeutics (SMMT) with an Outperform rating and $30 price target The firm sees lead asset, ...
The article humorously describes the 'evil twins' of each zodiac sign, focusing on their negative traits. From Aries' ...
Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results